MDxHealth Competitors and Similar CompaniesClear all

MDxHealth's competitors and similar companies include Veracyte, nRichDX, Protean BioDiagnostics and Nucleix.

	MDxHealth MDxHealth is a molecular diagnostics company that develops and commercializes tests for cancer and other urologic diseases diagnosis.	Veracyte Veracyte (formerly known as Calderome) is a genomic diagnostics company that specializes in molecular testing for the treatment of cancer.	nRichDX nRichDX is a biotech company providing liquid biopsy sample preparation for molecular testing.	Protean BioDiagnostics Protean BioDiagnostics is a reference laboratory that provides support to diagnose and manage community-based cancer patients and oncologists.	Nucleix Nucleix is a company that develops, manufactures, and markets non-invasive molecular cancer diagnostic tests.
Founding Date	Founding Date 2003	Founding Date 2008	Founding Date N/A	Founding Date 2017	Founding Date 2008
Type	Type Public	Type Public	Type Private	Type Private	Type Private
Tags	Tags Healthcare biotech medical devices medical diagnostics oncology	Tags Healthcare biotech genetics medical diagnostics	Tags Healthcare biotech platform	Tags Healthcare biotech medical devices medical diagnostics oncology	Tags Healthcare biotech medical devices medical diagnostics oncology
Locations	Locations Herstal, BE HQ Nijmegen, NL Irvine, US Plano, US	Locations South San Francisco, US HQ Marseille, FR Haifa, IL Austin, US San Diego, US	Locations Irvine, US HQ	Locations Orlando, US HQ	Locations Rehovot, IL HQ San Diego, US
Employees	Employees 252	Employees 8154% increase	Employees 18	Employees 2216% increase	Employees 72
Valuation ($)	Valuation ($) 93.5 m	Valuation ($) 2.6 b	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) $107.9m (FY, 2025)	Revenue (est.) $517.1m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A
Gross profit	Gross profit $71.8m (FY, 2025)	Gross profit $362.5m (FY, 2025)	Gross profit N/A	Gross profit N/A	Gross profit N/A
Net income	Net income ($33.5m) (FY, 2025)	Net income $66.4m (FY, 2025)	Net income N/A	Net income N/A	Net income N/A
Funding
Total funding raised	Total funding raised $ 1.1m	Total funding raised $ 116.3m	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 61m